Choroidal neovascularization secondary to sorsby fundus dystrophy treated with intravitreal bevacizumab.

Purpose: To report a case of extrafoveal choroidal neovascularization secondary to Sorsby fundus dystrophy that maintained 20/20 visual acuity over 14 months with intravitreal bevacizumab therapy.

Methods: Interventional case report of as-needed treatment with intravitreal bevacizumab of a 38-year-old lady with choroidal neovascularization from Sorsby fundus dystrophy.

Results: Three injections of intravitreal bevacizumab were given over 14.

Pulsed intravenous cyclophosphamide for sle retinal vasculitis.

Purpose: To report a case of systemic lupus erythematosus vaso-occlusive retinopathy with severe visual loss treated with intravenous pulsed cyclophosphamide.

Methods: Retrospective interventional case report.

Results: A 20-year-old Cambodian woman with newly diagnosed systemic lupus erythematosus presented with acute visual loss.

Atrial fibrillation following subconjunctival injection of mydricaine number 02.

Mydricaine is a mydriatic agent used as a subconjunctival injection to maintain perioperative mydriasis. The drug consists of a mixture of 1.3 mg atropine sulphate, 0.